Comfora (Elmiron)100mg 10 tab

$25.60

Each comfora contains 100 mg Pentosan Polysulfate Sodium 10 pills. Used for relief of chronic bladder pain associated with interstitial cystitis

ATC Classification: C05BA04, G04BX15
Active Ingrediant: Pentosan Polysulfate Sodium
Generic Name: Comfora
Manufacturer: Swati Spentose
Strength: 100mg
Dosage Type: Capsule
Packaging Type: Tab inBottle
Contains: 10 Caps

Examples of Packages sent

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Placeholder
Comfora (Elmiron)100mg 10 tab
$25.60

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Pentosan Polysulfate Sodium Information


What is this drug used for?

• It is used to ease pain, swelling, and irritation of the bladder.

 

Possible side effects

Pentosan Polysulfate Sodium may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• Diarrhea.
• Upset stomach.
• Headache.
• Hair loss.
• Dizziness.

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

• Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
• Signs of bleeding like throwing up or coughing up blood; vomit that looks like coffee grounds; blood in the urine; black, red, or tarry stools; bleeding from the gums; abnormal vaginal bleeding; bruises without a cause or that get bigger; or bleeding you cannot stop.
• Weight gain.
• Swelling.

 

Medication Safety Issues

Sound-alike/look-alike issues:

Pentosan may be confused with pentostatin

Elmiron may be confused with Imuran

 

Storage and Stability

Store at room temperature of 15°C to 30°C (59°F to 86°F).

 

Adverse Reactions

1% to 10%:

Central nervous system: Headache (3%), dizziness (1%)

Dermatologic: Alopecia (4%), skin rash (3%)

Gastrointestinal: Diarrhea (4%), nausea (4%), abdominal pain (2%), dyspepsia (2%)

Hematologic & oncologic: Rectal hemorrhage (6%)

Hepatic: Abnormal hepatic function tests (1%; dose-related)

<1%, postmarketing, and/or case reports: Amblyopia, anemia, anorexia, colitis, conjunctivitis, constipation, dehydration, depression, diaphoresis, dyspnea, ecchymoses, emotional lability, epistaxis, esophagitis, flatulence, gastritis, gingival hemorrhage, hyperkinetic muscle activity, hypersensitivity reaction, insomnia, leukopenia, maculopathy (Hanif 2019), optic neuritis, oral mucosa ulcer, pharyngitis, prolonged partial thromboplastin time, prolonged prothrombin time, pruritus, retinal hemorrhage, rhinitis, skin photosensitivity, thrombocytopenia, tinnitus, urticaria, vomiting –

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type